MELI vs MRK: Which Is the Better Buy?
Side-by-side comparison of MercadoLibre, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
MercadoLibre, Inc. · Consumer Cyclical
$1,767.42
+41.4% upside to fair value
High Conviction
Grade A
VS
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
MELI has more upside to fair value
(+41.4%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MELI |
MRK |
| Current Price |
$1,767.42 |
$121.42 |
| Fair Value Estimate |
$2,500.00 |
$118.00 |
| Upside to Fair Value |
+41.4%
|
-2.9%
|
| Market Cap |
$89.6B |
$300.2B |
| Forward P/E |
35.0x
|
14.0x
|
| EV / EBITDA |
18.5x
|
11.8x
|
| Price / Sales |
3.1x
|
4.1x
|
| Price / FCF |
8.9x
|
21.4x
|
| Revenue Growth YoY |
+39.1%
|
+1.3%
|
| Gross Margin |
44.5%
|
81.5%
|
| Operating Margin |
11.1%
|
41.2%
|
| Return on Equity |
33.7%
|
34.7%
|
| Dividend Yield |
0% |
3.1% |
| FCF Yield |
12.1%
|
4.7%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
MercadoLibre is the dominant e-commerce and fintech ecosystem across Latin America, operating the largest marketplace and digital payments platform in a region with 670M+ people where e-commerce penetration is still under 15%. Revenue grew 39% to $28.9B in FY2025 with $10.8B in free cash flow — a 12% FCF yield at current prices. The company is trading at its 5-year P/S minimum (3.1x) and P/FCF mi…
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Accumulation Zones
| Metric |
MELI |
MRK |
| Zone Low |
$1,875.00 |
$88.00 |
| Zone High |
$2,125.00 |
$100.00 |
| In Buy Zone? |
Yes
|
No
|